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only hints at Double-time (Dbt), a CK1/ subtype. Inter-
estingly, CK1 can phosphorylate -catenin, but not
prime GSK-3 phosphorylation (Vielhaber and Virshup,
2001; Gao et al., 2002). Instead, CK1 mediates Wnt
signaling by binding to the protein Dishevelled and may
cause dissociation of the Axin complex. It therefore acts
antagonistically to CK1and inhibits-catenin degrada-
tion. This raises the possibility that global changes of
CK1 activity could control the balance between Wnt and
Hh signaling; for example, increased activity could make
cells more sensitive to Wnt, but less sensitive to Hh.
A bank has partial control over many deposit boxes,
and likewise, could there be other regulatory elements
in common between Wnt and Hh signaling? Smooth-
ened and the Frizzled proteins share some sequence
similarity; perhaps they interact with common effectorPhosphorylation Sites on -Catenin and Ci (Site 2)
proteins? Both pathways require -Trcp, although it is
Priming phosphorylation is indicated by green arrows, and possible
not clear whether -Trcp can bind to fully phosphory-second priming site on -catenin (T42) is marked with a blue open
lated Ci as it contains no consensus binding site. Couldarrowhead.
Wnt and Hh pathways share other components to regu-
late GSK-3 or CK1 phosphorylation and the interaction
after overexpression of Wg, a Drosophila Wnt homolog. with -Trcp? What is clear is that these new observa-
This argues that the role of Axin is to bring together CK1 tions open further questions in Wnt and Hh signaling.
and GSK-3 to first prime and then fully phosphorylate
-catenin. In this way, only Axin-bound -catenin is effi-
Adrian J. Harwoodciently phosphorylated by GSK-3 and degraded. Inter-
MRC Laboratory for Molecular Cell Biology andestingly, the CK1 family is the other kinase group that
Department of Biologyrequires primed substrates, although they will also use
University College Londona site rich in acidic residues at a 100-fold lower efficiency
Gower Street(Flotow et al., 1990). CK1 phosphorylates at a site 3
London WC1E 6BTresidues to the C terminus of priming phosphate. This
United Kingdomposition in -catenin, residue 42, is a threonine (see
Figure), raising the possibility of a second priming kinase
that has yet to be identified.
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issue of Developmental Cell, two groups identify pro-Protein Tyrosine Phosphatase 1B:
tein tyrosine phosphatase 1B (PTP1B) as a cause ofA Potential Leptin Resistance leptin resistance through dephosphorylation of Jak2.
Factor of Obesity
The discovery of leptin in 1994 revolutionized concepts
of energy metabolism and feeding behavior. Epidemio-Indirect evidence implicates leptin resistance in the
logical and experimental evidence suggests that the rolepathogenesis of the lipotoxicity that complicates obe-
sity and results in the metabolic syndrome. In this of leptin is to prevent ectopic lipid overaccumulation
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How PTP1B Affects Leptin Signaling
(A) Depiction of the putative mechanism by
which PTP1B causes resistance to leptin sig-
naling believed to occur in diet-induced obe-
sity. Although leptin binds normally to its cell
surface receptor (1) and phosphorylates Jak2
(2), the receptor complex comes into proxim-
ity with PTP1B on the ER (3). There, PTP1B
dephosphorylates Jak2, blocking the phos-
phorylation of the receptor and Stat3 (4). Un-
phosphorylated Stat3 is therefore unable to
exert transcriptional control over its target
genes that encode enzymes of lipid homeo-
stasis. Consequently, ACC expression is ab-
normally high and CPT-1 is low (5); malonyl
CoA levels are elevated and they inhibit
CPT-1, thereby reducing oxidation of fatty
acids (6). This is believed to lead to steatosis,
lipotoxicity, and lipoapoptosis of nonadipo-
cytes.
(B) Depiction of mechanism of leptin sensitiv-
ity in PTP1B knockout mice. Steps (1) and (2)
are presumably the same as in (A). However,
PTP1B is absent and Stat3, phosphorylated
by Jak2 (3), enters the nucleus to alter the
transcription of its target genes (4). ACC and
FAS are downregulated and CPT-1 and ACO
are upregulated. The reduction of ACC ex-
pression, coupled with inactivation of the en-
zyme by AMP-activated kinase, a crucial con-
trol system not depicted here, reduces
malonyl CoA activity and thereby disinhibits
CPT-1 (5). Fatty acid synthesis is reduced,
FA-CoA oxidation increases, and normal in-
tracellular liporegulation is restored. ACC,
acetyl CoA carboxylase; FAS, fatty acid syn-
thase; CPT-1, carnitine palmitoyl transferase
1; ACO, acyl CoA oxidase; TG, triacylglycerol.
(Figure by K. McCorkle.)
during the development of obesity via direct peripheral (Wang et al., 1998). These studies suggest that a role
of leptin is to enhance tolerance to dietary fat and toaction on nonadipose tissues, thus sparing them the
metabolic trauma of lipid overload (Unger, 2002). When maintain fatty acid homeostasis.
Diet-induced obesity (DIO), the most common ofleptin action is lacking, the lipid content of liver, muscle,
and other nonadipose tissues is increased; derivatives American health problems, is also associated with hy-
perlipidemia, insulin resistance, hepatic steatosis, fattyof fatty acids, such as ceramide, impair their function
(lipotoxicity) and ultimately cause apoptosis (lipoapo- heart, coronary artery disease, and hypertension, collec-
tively termed “metabolic syndrome” or “syndrome x.” Inptosis; Shimabukuro et al., 1998). The clinical phenotype
of leptin deficiency in congenital generalized lipodystro- contrast to the congenital syndromes mentioned above,
the nonadipose tissues of individuals with DIO are as-phy includes hyperlipidemia, hepatic steatosis, insulin
resistance, diabetes, and cardiomyopathy, all of which sumed to be protected initially by the progressively in-
creasing hyperleptinemia. The late appearance of lipo-improve during treatment with recombinant leptin (Shi-
momura et al., 1999; Oral et al., 2002). A very similar toxic manifestations such as diabetes would then reflect
an acquired leptin resistance, presumably at a postre-phenotype is observed in rodents with a loss-of-function
mutation of the leptin receptor (OBR or LepR); gene ceptor level. Previously identified potential leptin resis-
tance factors include Socs-3, Shp2, and others (Bjor-transfer of wild-type OBR to the lipid-laden tissue of
leptin-unresponsive rats reverses the abnormalities baek et al., 2000).
Previews
387
It was previously observed that increased expression spatial and temporal relationships between the endocy-
tosed receptor complex and the PTP1B on the ER (seeof PTP1B in adipose tissue of obese patients with type 2
Figure).diabetes accounted for reduced tyrosyl phosphorylation
The leptin signaling pathway is a potential target forof the insulin receptor and reduced insulin signaling
drug therapy in the treatment of obesity, type 2 diabetes,(Ahmad et al., 1995). PTP1B knockout mice are hyper-
and other components of the metabolic syndrome. Ifsensitive to insulin, presumably as a result of increased
the rising plasma leptin levels of obesity initially protecttyrosyl phosphorylation of insulin receptors in skeletal
nonadipocytes from steatosis and lipotoxicity, the meta-muscle. They are resistant to obesity when fed a high-
bolic syndrome must represent resistance to leptin.fat diet, suggesting an increase in leptin sensitivity, a
Based on these studies, PTP1B is a highly plausiblesuspicion that is now convincingly verified by two stud-
candidate for a leptin resistance factor and inhibiting itsies published in this issue (Zabolotny et al., 2002; Cheng
activity may provide a therapeutic strategy to restoreet al., 2002).
leptin sensitivity and prevent disease in the nonadiposeZabolotny et al. (2002) demonstrate that PTP1B/
tissues. Additionally, if PTP1B activity is expressed in
mice are hypersensitive to leptin, exhibiting reduced
obese adipocytes, which are resistant to extremely high
serum leptin levels even on a high-fat diet. Destruction of leptin concentrations present in their interstitial fluid, its
OBR-expressing cells in the hypothalamus of PTP1B/ suppression might lower their fat content and reduce
mice using gold thioglucose caused only half as much obesity (“pharmacologic liposuction”).
weight gain as in wild-type controls, despite an equal
increase in food intake in both groups. These data sug- W.S. Cook1 and R.H. Unger1,2
gest that PTP1B may directly regulate leptin signaling 1Gifford Laboratories
in peripheral tissues, such as in muscle, fat, and/or liver. Touchstone Center for Diabetes Research
The mechanism of leptin signaling is depicted in the Department of Internal Medicine
Figure. Extracellular leptin binds the OBR dimer, leading University of Texas Southwestern Medical Center
to intracellular Jak2 transphosphorylation and activa- Dallas, Texas 75390
tion. Activated Jak2 phosphorylates Tyr1138 of OBR, 2 Veterans Affairs Medical Center
providing a binding site for Stat3. When Stat3 binds to Dallas, Texas 75216
OBR, it is phosphorylated by Jak2 and then travels into
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